Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Feb 15, 2024

Cisco Looks Cheap at 13x Forward Non-GAAP Earnings But Fundamentals Are Deteriorating
Image: Cisco has ratcheted down expectations during the past couple quarters, and its shares have been choppy for the better part of a year now. We’re not liking what we’re seeing from Cisco Systems these days, and this is a change from our generally more upbeat view during the past several months. Revenue is under pressure, guidance continues to come in lower than expectations, its balance sheet will weaken as a result of its pending deal for Splunk, and free cash flow trends haven’t been as strong as they used to be. The company is adjusting its cost structure with layoffs as it continues to work to transform its business model to be more recurring, but the near term will likely continue to be challenging for the company. If free cash flow does not meaningfully improve in the next couple quarters, we’ll look to remove Cisco from the newsletter portfolios, despite its attractive ~13x forward non-GAAP earnings multiple.

Feb 11, 2024

Eli Lilly’s Shares Have More Than Doubled During the Past 52 Weeks
Image: Eli Lilly’s shares have been on a tear these past few years. On February 6, Eli Lilly reported excellent fourth-quarter results that showed revenue and non-GAAP earnings per share coming in better than expectations. The company’s fourth-quarter results were bolstered by sales of diabetes and weight-loss drug Mounjaro, which saw sales in the quarter leap to ~$2.2 billion from ~$279 million in the year ago period. We continue to be in awe of the sales momentum behind GLP-1 receptor agonists, and the opportunity continues to be robust, despite already rapid sales acceleration. Though Eli Lilly trades at a premium to the high end of our fair value estimate range, we may be low in our expectations of the company’s ability to tap this lucrative market in the longer run, and shares may still be attractive to the risk-seeking aggressive growth investor.

Feb 7, 2024

Chipotle Rallies, Long-term Outlook Remains Promising
Image Source: Valuentum. We’re huge fans of Chipotle’s long-term growth runway, and we think the continued rollout of Chipotlanes offers the firm the ability to expand into the valuable breakfast daypart, which we think will come eventually. Its digital initiatives continue to work out well, too, with digital sales accounting for 36.1% of its total food and beverage revenue in the fourth quarter. Looking out to all of 2024, Chipotle expects full-year comparable restaurant sales growth in the mid-single-digit range and to add 285-315 new restaurants. The high end of our fair value estimate of Chipotle stands at $3,022 per share, and we continue to like shares in the Best Ideas Newsletter portfolio.

Feb 5, 2024

McDonald’s Facing Macro Challenges, Impacts from the War in the Middle East
Image Source: Mike Mozart. On February 5, McDonald’s Corp reported decent fourth-quarter results with strong revenue growth coming roughly in-line with consensus estimates and non-GAAP earnings per share exceeding the Street’s forecast. Though the firm noted that it is experiencing some macro challenges and that its operations continue to be impacted by the war in the Middle East, we like having McDonald’s as a core restaurant holding in the Best Ideas Newsletter portfolio in part because of its mostly franchised business model that handles inflationary pressures well and its strong and world-renowned brand name. The high end of our fair value estimate range of McDonald’s stands at $345 per share, and the company yields ~2.25% at the time of this writing.

Feb 4, 2024

Earnings Roundup: MO, EPD, SBUX, CLX, HON
Image: Starbucks’ international store growth potential remains robust. Image Source: Starbucks. High-yielding tobacco giant Altria offered an outlook through 2028 that spoke to continued robust earnings and dividend-per-share expansion. Enterprise Products Partners, now a Dividend Aristocrat, is handling record volumes through its pipeline network, and the firm is investing heavily to drive improved long-term cash flow trends. Starbucks recently disappointed on a number of metrics, but the company's margin and earnings performance remains excellent, as is its international store growth opportunities. Clorox has recovered nicely from a recent cyberattack, and the firm is now forecasting adjusted earnings per share growth in fiscal 2024. We're monitoring its cash flow trends closely, however. Honeywell is targeting tremendous free cash flow growth in 2024 thanks to continued strength in its commercial aerospace operations.

Feb 2, 2024

Earnings Roundup: ABBV, CVX, NYCB, XOM
Image: Unrealized losses continue to mount for banking entities due to the Fed's rate-hiking cycle. "Unrealized losses on securities totaled $683.9 billion in third quarter, up $125.5 billion (22.5 percent) from the prior quarter, primarily due to an increase in mortgage rates that reduced the value of mortgagebacked securities. Unrealized losses on held-to-maturity securities totaled $390.5 billion in the third quarter, while unrealized losses on available-for-sale securities totaled $293.5 billion." -- Image Source: FDIC Quarterly.AbbVie is facing pressure from declining sales of Humira, but the company's long-term outlook looks fine to us bolstered by promising growth of Skyrizi and Rinvoq. Chevron put up mixed fourth-quarter 2023 results, but its free cash flow easily covers its dividend payout. We've grown cautious on Chevron due to its deal making, however. New York Community Bancorp is provisioning for greater credit losses, while its net interest margin is under pressure. The bank recently slashed its payout, and we continue to reiterate why we don't like the dividends of banking firms. Exxon Mobil put up an excellent 2023, and while the firm's dividend is in great shape, we no longer are pursuing new energy-related ideas in the newsletter portfolios at this time.

Jan 26, 2024

Dividend Increases/Decreases for the Week of January 26
Let's take a look at firms raising/lowering their dividends this week.

Jan 25, 2024

Earnings Roundup: TSLA, NEE, IBM, CMCSA, NOW
Image: The Model Y was the best-selling vehicle globally in 2023. Image Source: Tesla. Tesla missed fourth-quarter results, and while the firm continues to generate robust free cash flow with a solid net cash position, uncertainty surrounding the name looms. NextEra makes the cut for ESG investors, and its earnings outlook for the next few years remains robust, even if its dividend growth may slow. IBM is back in growth mode, and the firm is looking to capitalize on watsonx and generative AI. Comcast has a lot of things going for it, and the firm's robust free cash flow generation suggests that future dividend growth will be robust, despite its lofty net debt position. ServiceNow continues to deliver for investors, and it continues to grow at a robust pace.

Jan 24, 2024

Earnings Roundup: NFLX, ASML, T, ABT
Image: Netflix’s substantially improved free cash flow has made it a clear winner in the streaming wars. Image Source: Netflix. Netflix has won the streaming wars and continues to throw off material free cash flow as it lands incremental deals, the latest for WWE Raw. ASML is one of the most prolific innovators in the semiconductor industry, and its quarterly net bookings in the fourth quarter reveal an exciting future, even as revenue is forecast to be flat in 2024. AT&T's earnings outlook for 2024 disappointed, and rising capital spending will pressure free cash flow in 2024. Dividend King Abbott Labs continues to drive strong organic growth rates, exclusive of COVID-19 related weakness, and we expect years of future dividend growth at the company.

Jan 22, 2024

Chinese Equities Still Uninvestable
Image: Large cap Chinese equities are back to levels first reached in 2005, almost two decades ago. Things have been so bad in Chinese equities that China’s largest broker has even taken steps to curb short sales. For the past 52 weeks, Alibaba’s shares have fallen more than 41%, Baidu’s shares have dropped more 22%, JD.com’s shares are off more than 63%, Bilibili’s shares are down more than 65%, while Tencent Holdings has fallen more than 30%. Though the steep declines in shares of Chinese equities may attract some bottom fishing, we’re not interested in any Chinese exposure at this time. We continue to like ideas in the newsletter portfolios.